Calendar Portage Biotech Inc.

Equities

PRTG

VGG7185A1286

Market Closed - Nasdaq 02:00:00 01/05/2024 am IST 5-day change 1st Jan Change
0.2431 USD -6.50% Intraday chart for Portage Biotech Inc. +0.21% -86.64%

Chart calendar Portage Biotech Inc.

fbdf0b67dbaa0e11cc2ef60536ba2e._fYKkEz2OvLZiwuZq8Jz6YUmNYRg0o3kmog9HcmgkZQ.u4I-8z-BTZDv7WfvxqUnk-hfRdc_uuG-2910aa3WweWit23DD7EPgL3-Wg~d73a15be9ae27ac6d22b2413e695e9d7

Upcoming events on Portage Biotech Inc.

29/07/2024 Q4 2024 Earnings Release (Projected)
26/08/2024 Q1 2025 Earnings Release (Projected)
26/11/2024 Q2 2025 Earnings Release (Projected)
26/02/2025 Q3 2025 Earnings Release (Projected)

Past events on Portage Biotech Inc.

29/02/2024 03:40 am Q3 2024 Earnings Release
29/11/2023 02:31 am Q2 2024 Earnings Release
28/09/2023 07:50 pm Cantor Global Healthcare Conference
12/09/2023 H.C. Wainwright Global Investment Conference
30/08/2023 05:30 pm Q1 2024 Earnings Release
01/08/2023 01:35 am Q4 2023 Earnings Release
08/06/2023 07:45 pm BIO International Convention - Panel
14/03/2023 11:30 pm Oppenheimer Healthcare Conference
09/03/2023 09:00 pm Investor Meeting - Key Opinion Leader
01/03/2023 06:30 pm Q3 2023 Earnings Release
22/02/2023 07:30 pm Citi Virtual Oncology Leadership Summit
30/11/2022 03:13 am Interim 2023 Earnings Release
10/11/2022 09:00 pm Annual General Meeting
10/11/2022 07:30 pm Society for Immunotherapy of Cancer Meeting - Abstract No. - 745
29/08/2022 05:30 pm Q1 2023 Earnings Release
01/08/2022 05:30 pm FY 2022 Earnings Release
07/07/2022 06:00 pm Acquisition of Tarus Therapeutics by Portage Biotech, Inc Call
06/06/2022 American Society of Clinical Oncology Meeting - Abstract Number: 2520
06/06/2022 American Society of Clinical Oncology Meeting - Abstract Number: 11515
06/06/2022 American Society of Clinical Oncology Meeting - Abstract Number: 382017

Annual results

Fiscal PeriodMarch 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-15,6
-15,3
-1.84%
-16,6
-18,0
7.92%

-19,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-14,8
-15,1
2.19%
-123
-18,0
-580.68%

-62,4

Net income
Million USD
Released
Forecast
Spread
-16,9
-13,7
-22.75%
-105
-16,0
-553.82%

-51,8

EPS
USD
Released
Forecast
Spread
-1,29
-1,05
-22.86%
-6,49
-0,94
-590.43%

-2,72

Announcement Date01/08/2231/07/23-

Quarterly results

Fiscal PeriodMarch 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-4,17
-3,60
-15.81%
-4,50
-4,24
-6%
-4,09
-4,38
6.67%
-3,65
-4,20
13.04%
-4,76
-3,88
-22.75%
-4,08
-5,00
18.48%
-5,00
-4,18
-19.62%
-5,93
-4,63
-27.99%
-4,03
-5,84
31.06%

-4,40

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4,09
-4,00
-2.23%
-4,05
-4,26
5.08%
-4,18
-4,35
3.87%
-3,64
-4,53
19.77%
-5,30
-3,88
-36.76%
-109
-5,00
-2088.1%
-6,07
-4,18
-45.33%
-6,07
-4,63
-31.06%
-48,9
-5,82
-740.07%

-4,35

Net income
Million USD
Released
Forecast
Spread
-3,51
-3,78
7.04%
-7,32
-3,78
-93.83%
-1,73
-4,05
57.26%
-0,95
-4,53
79.07%
-7,49
-3,88
-93.06%
-94,4
-5,00
-1788.96%
-5,92
-4,18
-41.69%
-5,16
-4,63
-11.33%
-39,4
-5,82
-576.74%

-4,35

EPS
USD
Released
Forecast
Spread
-0,26
-0,27
4.88%
-0,55
-0,28
-98.79%
-0,13
-0,30
56.18%
-0,06
-0,29
79.31%
-0,44
-0,23
-95.56%
-6,00
-0,27
-2122.22%
-0,33
-0,24
-37.5%
-0,29
-0,27
-7.41%
-1,88
-0,27
-596.3%

-0,22

Announcement Date24/02/2201/08/2229/08/2229/11/2201/03/2331/07/2329/08/2328/11/2328/02/24-

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PRTG Stock
  4. Calendar Portage Biotech Inc.